-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Sell Canopy Growth Shares Now Before CGC Loses Its Spark
Investors may not offer CGC stock a Constellation premium much longer, which means shares could head much lower.
Aurora Cannabis Stock Fell Again After Catalysts Faded
Aurora stock slid again, dropping below $2, driven by the fizzling of U.S. legalization hopes and weak demand for edibles in Canada.
Aurora Stock Remains a Great Trading Vehicle
While Aurora stock bulls are against the ropes they have relief lying just below current price. Meanwhile, ACB is a great trading vehicle.
Aurora Cannabis Must Win Back Investors’ Trust in 2020
To avoid further suffering, Aurora Cannabis must win back trust. To help ACB stock rally, it must grow revenue and launch 2.0 goods.
3 Reasons to Have Optimism in Canopy Growth Stock
Pot stocks are rising from the ashes, and Canopy Growth is leading the pack. That said, here are 3 reasons to be bullish on CGC stock.
Amarin Stock is Still Fully Valued Despite All the Good News
AMRN stock is likely fairly priced -- possibly even overpriced -- right now. It might take more time before analysts and the company actually raise their revenue and cash flow estimates based on patient uptake of Vascepa.
What Are Aurora Cannabis Investors Smoking?
Young investors continue to believe that ACB stock is a buy and that cannabis a wonder drug. Their fathers believed in North Dakota oil.
Aphria Stock is Likely Stuck Biding Time til the Pot Grower Gets Profitable
Aphria stock is biding time until the company gets profitable. Unless profits appear soon, Aphria stock may be headed further down.
Aurora Cannabis Teaches a Great Lesson on Ignoring the Gurus
After some shockingly low price targets, it seems to me the analysts are wrong about ACB stock. It might finally be making a comeback.
A Huge Year for Aurora Cannabis Stock Is Off to a Wild Start
Aurora stock is up about 8% so far in 2020, but the ride has been anything but smooth. Will Cannabis 2.0 provide a long-awaited catalyst?
Can You Call It a Comeback for Canopy Growth Stock?
CGC stock is rebounding to start 2020, but it's going to take more to convince investors this will be a name that leads cannabis this year.
Aurora Cannabis Stock Will Need Help for a 2020 Recovery
Aurora Cannabis has recently perked up, but plenty of challenges remain for ACB stock and upside could be limited over the course of 2020.
Buffett Owns Teva Stock, But Should You?
Teva stock has been a long-term loser, but there are signs that things are starting to turn around. Should investors consider it in 2020?
The Prognosis for CVS is Strong
Healthcare stocks like, CVS Health Corporation (NYSE:CVS) are going get a lot of attention during this presidential election.
Ocugen Stock Might be up 34% in 2020 but There are Other Eye Care Plays
Except for a couple of specific investors, Ocugen stock is not one for average people. Instead, look at Bausch Health Companies, which has a very rocky backstory but has managed to turn the corner.
Is It Finally Time to Buy Aurora Cannabis Stock?
Aurora stock has tumbled to fresh lows, but analysts are divided on whether the drop is a buying opportunity. There are still plenty of risks ahead for Aurora, and there are better cannabis stocks out there.
